Dachaigh › Sclerosis iomaill › Alabama
Sgrùdaidhean clionaigeach Sclerosis iomaill ann an Alabama
Tha 8 sgrùdaidhean airson Sclerosis iomaill a’ lorg phàirtichean aig làraichean ann an Alabama.
Bailtean ann an Alabama
Teacsa sgrùdaidh oifigeil (Beurla)
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
- Alabama Neurology Associates, Birmingham
A’ fastadhÌre 2
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06782490Understanding the Impact of Meal Timing on Neurological Health in Adults With Multiple Sclerosis
- University of Alabama at Birmingham, Birmingham
A’ fastadh
Aoisean 18 gu 64 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07475377A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Birmingham
- TG Therapeutics Investigational Trial Site, Cullman
- TG Therapeutics Investigational Trial Site, Huntsville
- agus 1 a bharrachd
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT06433752RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- UAB, Psychiatry and Behavioral Neurology, Birmingham
A’ fastadhÌre 2
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT07002034Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- North Central Neurology Associates- Site Number : 8401100, Cullman
- Alabama Neurology Associates- Site Number : 8400115, Homewood
A’ fastadhÌre 3
Aoisean 18 gu 60 · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT07325292A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Alabama Neurology Associates PC, Birmingham
A’ fastadhÌre 3
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 29 Iuch 2026 · NCT07225504Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
- University of Alabama at Birmingham Medical Center, Birmingham
A’ fastadhÌre 1Fàilte do shaor-thoilich fhallain
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 2 Ògmh 2026 · NCT03759522Care in Multiple Sclerosis (MS)
- University of Alabama at Birmingham, Birmingham
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Cèit 2026 · NCT07011914Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.